Report for Siegbahn A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease - Wallentin_2016_J.Am.Heart.Assoc_5_
Author(s) : Wallentin L , Held C , Armstrong PW , Cannon CP , Davies RY , Granger CB , Hagstrom E , Harrington RA , Hochman JS , Koenig W , Krug-Gourley S , Mohler ER, 3rd , Siegbahn A , Tarka E , Steg PG , Stewart RA , Weiss R , Ostlund O , White HD
Ref : J Am Heart Assoc , 5 : , 2016
Abstract : Wallentin_2016_J.Am.Heart.Assoc_5_
ESTHER : Wallentin_2016_J.Am.Heart.Assoc_5_
PubMedSearch : Wallentin_2016_J.Am.Heart.Assoc_5_
PubMedID: 27329448

Title : Genetic determinants of dabigatran plasma levels and their relation to bleeding - Pare_2013_Circulation_127_1404
Author(s) : Pare G , Eriksson N , Lehr T , Connolly S , Eikelboom J , Ezekowitz MD , Axelsson T , Haertter S , Oldgren J , Reilly P , Siegbahn A , Syvanen AC , Wadelius C , Wadelius M , Zimdahl-Gelling H , Yusuf S , Wallentin L
Ref : Circulation , 127 :1404 , 2013
Abstract : Pare_2013_Circulation_127_1404
ESTHER : Pare_2013_Circulation_127_1404
PubMedSearch : Pare_2013_Circulation_127_1404
PubMedID: 23467860